BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 9052504)

  • 1. Pancreatic fluid hypersecretion in rats after acute pancreatitis.
    Czakó L; Yamamoto M; Otsuki M
    Dig Dis Sci; 1997 Feb; 42(2):265-72. PubMed ID: 9052504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCK administration after CCK receptor blockade accelerates recovery from cerulein-induced acute pancreatitis in rats.
    Nakano S; Kihara Y; Otsuki M
    Pancreas; 1998 Mar; 16(2):169-75. PubMed ID: 9510141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the cholecystokinin receptor antagonist loxiglumide on pancreatic exocrine function in rats after acute pancreatitis.
    Nakano S; Tachibana I; Otsuki M
    Pancreas; 1995 Apr; 10(3):287-94. PubMed ID: 7542770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exocrine pancreatic function in rats after acute pancreatitis.
    Czakó L; Yamamoto M; Otsuki M
    Pancreas; 1997 Jul; 15(1):83-90. PubMed ID: 9211497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fasting prevents acute pancreatitis induced by cerulein in rats.
    Otsuki M; Tani S; Okabayashi Y; Fujii M; Nakamura T; Fujisawa T; Koide M; Itoh H
    Dig Dis Sci; 1990 Jul; 35(7):840-8. PubMed ID: 2364838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCK-, secretin-, and cholinergic-independent pancreatic fluid hypersecretion in protease inhibitor-treated rats.
    Yamamoto M; Shirohara H; Otsuki M
    Am J Physiol; 1998 Feb; 274(2):G406-12. PubMed ID: 9486196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with cholecystokinin receptor antagonist loxiglumide enhances insulin response to intravenous glucose stimulation in postpancreatitic rats.
    Otsuki M; Nakano S; Tachibana I
    Regul Pept; 1994 Jul; 52(2):85-95. PubMed ID: 7972939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of MCI-727 on pancreatic exocrine secretion and acute pancreatitis in two experimental rat models.
    Tachibana I; Watanabe N; Shirohara H; Akiyama T; Nakano S; Otsuki M
    Pancreas; 1996 Mar; 12(2):165-72. PubMed ID: 8720664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chronic administration of hydrocortisone on the induction and evolution of acute pancreatitis induced by cerulein.
    Pescador R; Manso MA; Rebollo AJ; de Dios I
    Pancreas; 1995 Aug; 11(2):165-72. PubMed ID: 7479674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of the synthetic trypsin inhibitor camostate in cerulein-induced acute pancreatitis in rats.
    Otsuki M; Tani S; Okabayashi Y; Fuji M; Nakamura T; Fujisawa T; Itoh H
    Dig Dis Sci; 1990 Feb; 35(2):242-50. PubMed ID: 1689237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin antagonist prevents hyperamylasemia and improves pancreatic exocrine function in cerulein-induced acute pancreatitis.
    Murayama KM; Drew JB; Nahrwold DL; Joehl RJ
    Pancreas; 1990 Jul; 5(4):439-44. PubMed ID: 1696383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerulein-induced acute pancreatitis in the rat. Study of pancreatic secretion and plasma VIP and secretin levels.
    Manso MA; San Román JI; de Dios I; García LJ; López MA
    Dig Dis Sci; 1992 Mar; 37(3):364-8. PubMed ID: 1370934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cholecystokinin1 receptor antagonist loxiglumide (CR1505) on basal pancreatic exocrine secretion in conscious rats.
    Ishizaki K; Kinbara S; Kawamura M; Kimura K; Shiratori K; Takeuchi T
    Pancreas; 2003 Jan; 26(1):87-91. PubMed ID: 12499923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the cholecystokinin A receptor antagonist loxiglumide on the proliferation and cell cycle time of pancreatic acinar cells in rats.
    Kanemitsu D; Sakagami J; Motoyoshi T; Nakajima T; Kataoka K
    Pancreas; 2006 Mar; 32(2):190-6. PubMed ID: 16552340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of loxiglumide on pancreatic exocrine secretion stimulated by meal in conscious dogs.
    Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Edano K; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1998 Jan; 48(1):55-7. PubMed ID: 9522033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a new cholecystokinin receptor antagonist loxiglumide on acute pancreatitis in two experimental animal models.
    Tani S; Okabayashi Y; Nakamura T; Fujii M; Itoh H; Otsuki M
    Pancreas; 1990 May; 5(3):284-90. PubMed ID: 2343042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma amino acid consumption and pancreatic secretion during and after cerulein-induced pancreatitis in rats.
    Fischer H; Konturek JW; Szlachcic A; Konturek SJ; Domschke W
    Int J Pancreatol; 1995 Oct; 18(2):127-34. PubMed ID: 8530828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic exocrine function during acute exacerbation in WBN/Kob rats with spontaneous chronic pancreatitis.
    Sugiyama M; Kobori O; Atomi Y; Wada N; Kuroda A; Muto T
    Int J Pancreatol; 1996 Dec; 20(3):191-6. PubMed ID: 9013280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caerulein-induced acute pancreatitis in the rat. Pancreatic secretory response to cholecystokinin.
    San Román JI; De Dios I; Manso MA; Calvo JJ; López MA
    Arch Int Physiol Biochim; 1990 Oct; 98(5):237-43. PubMed ID: 1708991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tetraprenylacetone on pancreatic exocrine secretion and acute pancreatitis in two experimental models in rats.
    Tachibana I; Watanabe N; Shirohara H; Akiyama T; Nanano S; Otsuki M
    Int J Pancreatol; 1995 Apr; 17(2):147-54. PubMed ID: 7542690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.